ArticleKidney international reports2020

Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.

Paolo Raggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.